Clinical Trials · NCT00806468

Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease

TerminatedPhase 4Desmopressin (Prohibited)
Phase
Phase 4
Recruitment status
Terminated
Sponsor
Johannes Gutenberg University Mainz
Enrollment
1
Start date
Feb 2009
Locations
1 site, Germany
Primary endpoint
average nocturnal micturition frequency within the 2 weeks treatment phase each
View Desmopressin compound reference